J&J Returns $85 Billion to Shareholders: A Deep Dive
Infographic: Johnson & Johnson Stock Delivers $85 Billion Shareholder Gain
Key Highlights
Johnson & Johnson (JNJ) has distributed $85 billion to shareholders over 5 years via dividends & buybacks. Explore its financial health and growth prospects.
Johnson & Johnson (JNJ) has delivered a significant $85 billion to its shareholders over the last five years through a combination of dividends and share repurchases. This places the pharmaceutical giant 13th historically for total capital returned to shareholders.
Key Shareholder Returns
- A total of $85 billion was returned to shareholders over five years.
- This includes $59 billion in dividends.
- An additional $26 billion came from share repurchases.
- JNJ’s total return as a percentage of its current market cap stands at 14.8%.
Financial Health & Growth Context
While JNJ’s 14.8% return is slightly below the S&P median of 16.9%, the company demonstrates robust financial health. Its strong cash generation capabilities are evident.
- Last twelve months (LTM) revenue growth: 7.9%.
- Last 3-year average revenue growth: 4.4%.
- Free cash flow margin: 18.1%.
- Operating margin LTM: 26.8%.
- JNJ stock currently trades at a multiple of 27.6.
Capital Returns vs. Growth Prospects
High capital returns can sometimes indicate an inverse relationship with growth prospects. Faster-growing companies such as Meta and Microsoft typically return a smaller fraction of their market cap to shareholders, focusing instead on reinvestment for future expansion.